Active Ingredient: OLEZARSEN SODIUM
Proprietary Name: TRYNGOLZA (AUTOINJECTOR)
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 80MG BASE/0.8ML (EQ 80MG BASE/0.8ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218614
Product Number: 001
Approval Date: Dec 19, 2024
Applicant Holder Full Name: IONIS PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
